Currently, there are 636.92M common shares owned by the public and among those 603.40M shares have been available to trade.
The company’s stock has a 5-day price change of 8.59% and -47.15% over the past three months. GERN shares are trading -60.73% year to date (YTD), with the 12-month market performance down to -64.36% lower. It has a 12-month low price of $1.17 and touched a high of $5.34 over the same period. GERN has an average intraday trading volume of 15.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.24%, -4.60%, and -56.38% respectively.
Institutional ownership of Geron Corp (NASDAQ: GERN) shares accounts for 75.67% of the company’s 636.92M shares outstanding.
It has a market capitalization of $885.32M and a beta (3y monthly) value of 0.61. The earnings-per-share (ttm) stands at -$0.21. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.40% over the week and 8.02% over the month.
Earnings per share for the fiscal year are expected to increase by 52.66%, and 65.39% over the next financial year.
Looking at the support for the GERN, a number of firms have released research notes about the stock. Scotiabank stated their Sector Perform rating for the stock in a research note on May 08, 2025, with the firm’s price target at $1.50. B. Riley Securities coverage for the Geron Corp (GERN) stock in a research note released on February 27, 2025 offered a Neutral rating with a price target of $2. H.C. Wainwright was of a view on February 26, 2025 that the stock is Neutral, while H.C. Wainwright gave the stock Buy rating on November 05, 2024, issuing a price target of $8. Scotiabank on their part issued Sector Outperform rating on October 16, 2024.
